9 th July 2019 – Global Disposable Syringe Market research report provides a specific tool for evaluating the Industry, highlighting opportunities, and supporting strategic and tactical decision-making. This study identifies that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and development. It provides information on trends and developments, and focuses on markets capacities and on the changing structure of the Disposable Syringe. In addition, the research evaluated key market aspects, comprising capacity utilization rate, revenue, price, capacity, growth rate, gross, production, consumption, supply, export, market share, cost, import, gross margin, demand, and much more. Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/disposable-syringe-market-outlook/request-sample Global disposable syringe market is expected to grow a...
14th
May 2019 - A
dry powder inhaler (DPI) is a kind of inhaler often used to deliver medications
such as inhaled corticosteroids into the lungs. Rapid
surge in the market is credited to the prevalence of respiratory diseases such
as chronic obstructive pulmonary diseases and asthma, and rising air pollution
levels, particularly in developing economies across the globe. Rising efforts
by local governments for improving existing healthcare infrastructure and
growing awareness levels are expected to drive the growth of the market over
the forecast period.
The global dry powder inhaler market
is expected to display higher growth rate in the upcoming period.
Rising demand and consumption of dry powder inhalers is credited to the
surging per capita health care expenditure by regional governments across the
globe. Growing preference towards self-administered drug therapies and
home-based healthcare services are anticipated to fuel market demand for dry
powder inhaler market over the forecast period. Globally, market is predicted
to generate massive revenue over the forecast period, providing numerous
opportunities for industry participants to invest in research and development
of dry powder inhalers.
Growing consumption of nicotine and tobacco-based product is propelling
sales of dry powder inhaler over the past few years. Development of inexpensive
therapies associated with different respiratory diseases, and soaring demand
for low-cost devices from developing & underdeveloped economies across the
globe is further fostering market growth over the past few years.
Several healthcare facilities are allowing patient to share multi-use
devices among multiple patient due to unaffordability. However, launch of
single-use devices, which are highly cost efficient, has overcome these
challenges and offer a hygienic & clean device to use. These factors are
further complementing to sustained market growth over the past few years.
The dry powder inhaler market is broadly categorized into three major
segments based on the product type such as capsule based dry powder inhaler
device, blister based powder inhaler device, and reservoir/cartridge based
powder inhaler device. Capsule based dry powder inhaler device segment is
growing rapidly in the market with substantial revenue generation in the last
few years. Growing popularity of capsule based dry powder inhaler device
segment is attributed to the increasing product penetration in newer market and
cost-effectiveness.
The dry powder inhaler market is divided by region as North America,
Europe, Asia-Pacific, Latin America and Africa. North America has shown major
growth in recent years owing to the rise in implementation of latest
technologies in medicine & pharmaceutical sector, surge in number of
research & development activities and existence of well-established
healthcare infrastructure in the region. In European region, Germany, France
and United Kingdom are projected to witness steady growth over the past few
years.
Asia-Pacific region is estimated to hold a major share in the market with
massive growth in forecast period. Countries such as India, China and Singapore
are leading the Asia-Pacific market with strong economic growth, rising
healthcare expenditure, increasing awareness level among general population,
growing consumer base, and significant investment by leading industry players
considering potential growth opportunities in the region.
The key players in the dry powder inhaler market are Mannkind Corp.,
Cipla Inc., Hovione FarmaCiencia S.A., GlaxoSmithKline plc, Meda
Pharmaceuticals Inc., The 3M Company, AstraZeneca plc, Vectura Group plc,
Teicos Pharma Ltd., and Teva Pharmaceutical Industries.
Request
a Free Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/dry-powder-inhaler-market/request-sample
Comments
Post a Comment